Molecular Partners Ag (MOLN) Assets Average (2021 - 2026)

Molecular Partners Ag (MOLN) has reported Assets Average for 6 consecutive years, with $103.9 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Assets Average fell 32.34% year-over-year to $103.9 million in Q2 2026; TTM through Jun 2026 was $103.9 million, a 32.34% decrease from a year earlier, with the FY2025 full-year figure at $151.7 million, down 24.36% from the prior year.
• Assets Average was $103.9 million for Q2 2026 at Molecular Partners Ag, down from $119.8 million in the prior quarter.
• Over five years, Assets Average peaked at $324.2 million in Q2 2022 and troughed at $103.9 million in Q2 2026.
• A 5-year average of $210.7 million and a median of $209.4 million in 2024 frame the typical range for Assets Average.
• Across the five-year window, Assets Average surged 48.51% in 2022 and tumbled 32.34% in 2026, its largest moves.
• Over 5 years, Assets Average stood at $281.7 million in 2022, then dropped by 16.47% to $235.3 million in 2023, then declined by 23.72% to $179.5 million in 2024, then retreated by 25.35% to $134.0 million in 2025, then slipped by 22.48% to $103.9 million in 2026.
• The last three Assets Average figures came in at $103.9 million (Q2 2026), $119.8 million (Q1 2026), and $134.0 million (Q4 2025), per Business Quant data.